1. Home
  2. IKT vs DM Comparison

IKT vs DM Comparison

Compare IKT & DM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • DM
  • Stock Information
  • Founded
  • IKT 2008
  • DM 2015
  • Country
  • IKT United States
  • DM United States
  • Employees
  • IKT N/A
  • DM N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • DM Industrial Machinery/Components
  • Sector
  • IKT Health Care
  • DM Technology
  • Exchange
  • IKT Nasdaq
  • DM Nasdaq
  • Market Cap
  • IKT 159.2M
  • DM 153.0M
  • IPO Year
  • IKT 2020
  • DM N/A
  • Fundamental
  • Price
  • IKT $2.31
  • DM $4.43
  • Analyst Decision
  • IKT Strong Buy
  • DM Hold
  • Analyst Count
  • IKT 2
  • DM 1
  • Target Price
  • IKT $6.50
  • DM $5.50
  • AVG Volume (30 Days)
  • IKT 310.9K
  • DM 296.1K
  • Earning Date
  • IKT 11-14-2024
  • DM 10-31-2024
  • Dividend Yield
  • IKT N/A
  • DM N/A
  • EPS Growth
  • IKT N/A
  • DM N/A
  • EPS
  • IKT N/A
  • DM N/A
  • Revenue
  • IKT $1.00
  • DM $168,283,000.00
  • Revenue This Year
  • IKT N/A
  • DM $1.01
  • Revenue Next Year
  • IKT N/A
  • DM N/A
  • P/E Ratio
  • IKT N/A
  • DM N/A
  • Revenue Growth
  • IKT N/A
  • DM N/A
  • 52 Week Low
  • IKT $0.85
  • DM $3.62
  • 52 Week High
  • IKT $3.82
  • DM $11.80
  • Technical
  • Relative Strength Index (RSI)
  • IKT 52.09
  • DM 45.97
  • Support Level
  • IKT $1.75
  • DM $4.10
  • Resistance Level
  • IKT $2.10
  • DM $4.57
  • Average True Range (ATR)
  • IKT 0.33
  • DM 0.23
  • MACD
  • IKT -0.10
  • DM -0.02
  • Stochastic Oscillator
  • IKT 28.87
  • DM 55.75

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About DM Desktop Metal Inc.

Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.

Share on Social Networks: